RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 16 - per page Next page
Order by
ORS effervescent tablet (Oral Rehydration Salts)
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Cellophil™ Biomedical Polymers - New and superior biomedical polymers for drug delivery and new standards in the medical device industry
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
An OTC benign mucosal protective throat spray; capable of relieving chronic sore throat, cough, hoarseness, and post-nasal drip; the symptoms of acid reflux in addition to environmental and other throat conditions.
Powder spray providing a benign mucosal barrier over the entire throat, combating the reflux related symptoms of stomach acid and enzymes in the throat, utilizing a purified, organic, safe and effective natural compound. More
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Multilayered controlled release oral solid pharmaceutical forms
Multilayered controlled release oral solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. More
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Stabilisation and rapid reconstitution of biopharmaceuticals
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
New Efficient Manufacturing Process For Biodegradable Microspheres With Controlled Release Properties For Biological Pharmaceutical Agents
Device and Process for Economical, Semi-Continuous Biodegradable Microsphere Production More
Polysaccharide Derived Nitric Oxide Releasing Carbon Bound Diazeniumdiolates
A method for producing nitric oxide (NO)-releasing derivatives of any material containing a reducing sugar component More
Displaying 1..10 of 16 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Gastrointestinal Drug Discoveries
Jan 2008 - 148 pages - $1,740
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV)
Jun 2009 - 118 pages - $1,040
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech
Nov 2010 - 428 pages - $2,695
Who's Developing What in Drug Delivery 2009
Nov 2009 - 830 pages - $1,040
Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2018 (Volume III)
Jun 2009 - 110 pages - $1,040
Company Financials: Depomed, Inc.
Jan 2010 - $75
Hokkaido Gastrointestinal Cancer Study Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 30 pages - $500
Spanish Cooperative Group for Gastrointestinal Tumour Therapy – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 41 pages - $500
Spanish Cooperative Group for Gastrointestinal Tumour Therapy – Developmental Therapeutics Review – Q1 2011
Mar 2011 - 41 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us